Pharmaceutical

City Therapeutics launches with $135m Series A funding

City Therapeutics has announced its launch accompanied by a $135m Series A financing to lead advancements in RNAi-based medicine.

Oct 10, 2024 - 04:00
City Therapeutics launches with $135m Series A funding
City Therapeutics has announced its launch accompanied by a $135m Series A financing to lead advancements in RNAi-based medicine.
Read the original article

Tags:

Previous Article

Clinical Dose Companies in Contract Manufacturing for the Pharmaceutical Industry

Next Article

Ipsen’s Elafibranor gains MHRA approval for PBC treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Key Senate panel has a plan for PBMs; Roivant eyes $7 billion sale of a stomach drug

STAT+: Pharmalittle: Key Senate panel has a plan for PB...

Jul 14, 2023

Cambridge biotech Thymmune wins $37m NIH grant for thymic cell therapies

Cambridge biotech Thymmune wins $37m NIH grant for thym...

Sep 29, 2023

Unresolved clawback issues obstruct Greece’s potential pharmaceutical framework agreement

Unresolved clawback issues obstruct Greece’s potential ...

Oct 20, 2024